MSLE - Satellos Bioscience Inc. News

Sectors

MSLE

Satellos Bioscience Inc.

9.34

1 x 10.20

1 x 10.15

bid

ask

0.46

5.12%

1 @ 04:10 PM

9.34 +0.00 (0.00%)

Ytd	58.84%
1y	78.93%

8.68

day range

9.44

5.30

52 week range

13.39

Open	8.78	Prev Close	8.88	Low	8.68	High	9.44	Mkt Cap	198.16M
Vol	53.27K	Avg Vol	54.12K	EPS	-1.95	P/E	N/A	Forward P/E	N/A
Beta	1.51	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	11-12	50-d Avg	8.93	200-d Avg	8.05	1yr Est	0.00

MSLE News

benzinga.com

HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy

benzinga.com

Satellos Bioscience Q2 EPS $(0.56) Misses $(0.45) Estimate

Satellos Bioscience (NASDAQ:MSLE) reported quarterly losses of $(0.56) per share which missed the an

benzinga.com

HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy

benzinga.com

Satellos Bioscience Duchenne Drug Candidate's Interim Data Boosts Confidence

Recently listed, Satellos Bioscience Inc. (NASDAQ:MSLE) on Wednesday reported six-month interim data

benzinga.com

Satellos Bioscience Duchenne Drug Candidate's Interim Data Boosts Confidence

Satellos reports six-month interim data showing SAT-3247 improved muscle composition, maintained str

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday'

benzinga.com

Satellos Bioscience Announces Six-Month Interim Data From TRAILHEAD Evaluating SAT-3247 In Adults Wi

Fat fraction mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesti

benzinga.com

Satellos Gets FDA Fast Track Status For Duchenne Drug

Satellos Bioscience Inc. (NASDAQ:MSLE, TSX:MSCL) ("Satellos" or the "Company"), a cl

globenewswire.com

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Sate

globenewswire.com

Satellos to Participate in Upcoming Investor Conferences

TORONTO, May 27, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satel

benzinga.com

HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy

benzinga.com

Earnings Scheduled For May 15, 2026

benzinga.com

Satellos Bioscience Q1 EPS $(0.53) Down From $(0.44) YoY

Satellos Bioscience (NASDAQ:MSLE) reported quarterly losses of $(0.53) per share. This is a 20.45 pe

benzinga.com

Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Satellos Bioscience (NASDAQ:MSLE) w

247wallst.com

Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense,

Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter ea

benzinga.com

HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations Fo

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst r

benzinga.com

Cantor Fitzgerald Initiates Coverage On Satellos Bioscience with Overweight Rating

Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Satellos Bioscience (NASDAQ:MS

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session